WANTAI BIOLOGICAL(SH:603392) Zhong Guo Xin Wen Wang·2025-09-10 08:24Core Viewpoint - The launch of the domestically developed nine-valent HPV vaccine "Xinkening®9" in Xiamen represents a significant advancement in cervical cancer prevention for women aged 9 to 45, offering a more accessible and affordable health protection option [1][3]. Group 1: Vaccine Launch and Pricing - The first dose of the domestic nine-valent HPV vaccine was administered on September 9, 2025, marking a milestone in public health [1][3]. - The price of the domestic vaccine is set at 499 yuan per dose, approximately 40% of the cost of imported vaccines, which can reach nearly 4000 yuan for a full course [3][4]. - The total cost for the vaccination program is 998 yuan for females aged 9-17 (two doses) and about 1500 yuan for those aged 18-45 (three doses), significantly lowering the financial barrier for vaccination [3][4]. Group 2: Clinical Trials and Efficacy - Clinical trials for the vaccine included over 10,000 Chinese women aged 9 to 45, demonstrating protection efficacy comparable to imported vaccines [6]. - The vaccine is particularly advantageous for the 15-17 age group, requiring only two doses to complete the vaccination schedule, enhancing accessibility and convenience [6][7]. Group 3: Production and Quality Control - The vaccine was developed by a team from Xiamen University and Wantai Biological Pharmacy, utilizing a unique bacterial expression technology, which breaks through existing patent barriers and ensures large supply and reasonable pricing [4][5]. - Wantai Biological emphasizes high production standards, with minimal variability in key parameters between batches, ensuring consistency and reliability [5]. Group 4: Future Implications and Goals - The successful rollout of the vaccine is expected to expand production capacity and implement public welfare measures, making the vaccine more accessible and affordable [7]. - This initiative aligns with the broader goal of achieving "Healthy China 2030," providing a solid foundation for health protection among women of appropriate ages [7].